Prescribing benzodiazepines in general practice: A new view of an old problem

Health

Volumn 11, Issue 2, 2007, Pages 181-198

  Rogers, Anne ^a   Pilgrim, David ^b,c   Brennan, Susie ^a   Sulaiman, Ilyas ^a   Watson, Gareth ^a   Chew Graham, Carolyn ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Teaching Primary Care Trust for East Lancashire   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Benzodiazepines; GPs' perspectives; Narratives; Psychotropic medication

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE;

DRUG UTILIZATION; GENERAL PRACTICE; HEALTH PERSONNEL ATTITUDE; HUMAN; QUALITATIVE RESEARCH; REVIEW; SOCIOLOGY; UNITED KINGDOM; VERBAL COMMUNICATION;

ANTI-ANXIETY AGENTS; ATTITUDE OF HEALTH PERSONNEL; BENZODIAZEPINES; DRUG UTILIZATION; FAMILY PRACTICE; GREAT BRITAIN; HUMANS; NARRATION; QUALITATIVE RESEARCH; SOCIOLOGY, MEDICAL;

EID: 33847346797     PISSN: 13634593     EISSN: 14617196     Source Type: Journal    
DOI: 10.1177/1363459307074693     Document Type: Review

References (32)

1. Baldessarini, R.J. (1999). Psychopharmacology. In A.M. Nicholi (Ed.), The Harvard guide to psychiatry, pp. 76 - 98. Harvard: Belknap.
2. Beck, U. (1992). The risk society: Towards a new modernity. London: Sage.
3. Breggin, P. (1993). Toxic psychiatry. London: HarperCollins.
4. Britten, N., Stevenson, F., Gafaranga, J., Barry, C. and Bradley, C. (2004). The expression of aversion to medicines in general practice consultations. Social Science & Medicine, 59 (7). 1495 - 1503.
5. Brown, P. and Funk, S.C. (1986). Tardive dyskinesia: Barriers to the professional recognition of iatrogenic disease. Journal of Health and Social Behavior, 27 (2). 116 - 132.
6. Bury, M. and Gabe, J. (1990). Hooked? Media responses to tranquillizer dependence. In P. Abbott and G. Payne (Eds.), New directions in the sociology of health, pp. 87 - 103. London: Falmer Press.
7. Cohen, S. (1983). Current attitudes about the benzodiazepines: Trial by media. Journal of Psychoactive Drugs, 15 (1-2). 109 - 113.
8. Committee on the Safety of Medicines. (1988). Benzodiazepines, dependence and withdrawal symptoms. Current Problems, 21.
9. Cooperstock, R. (1978). Sex differences in psychotropic drug use. Social Science and Medicine, 1 (12). 179 - 186.
10. Fisher, S. and Greenberg, R.P., Eds. (1997). From placebo to panacea: Putting psychiatric drugs to the test. New York: Wiley.
11. Gabe, J. and Thorogood, N. (1986). Prescribed drug use and the management of everyday life: The experience of white working class women. Sociological Review, 34 (4). 737 - 772.
12. Giddens, A. (1991). Modernity and self identity: Self and society in the late modern age. Cambridge: Polity.
13. Hamilton, I.J., Reay, L.M. and Sullivan, F.M. (1990). A survey of general practitioners' attitudes to benzodiazepine overprescribing. Health Bulletin, 48 (6). 299 - 303.
14. Healy, D. (1997). The anti-depressant era. London: Harvard University Press.
15. Jeffries, R. (1979). 'Normal rubbish': Deviant patients in casualty departments. Sociology of Health and Illness, 1 (1). 90 - 109.
16. Lacey, R. (1991). The MIND complete guide to psychiatric drugs. London: MIND.
17. Lader, M., Beaumont, G. and Bond, A. (1992). Guidelines for the management of patients with generalized anxiety. Psychiatric Bulletin, 16, 560 - 565.
18. Lester, H.E., Tritter, J.Q. and Sorohan, H. (2005). Patients' and health professionals' views on primary care for people with serious mental illness: Focus group study. British Medical Journal, 330, 1126 - 1126B.
19. May, C., Allison, G., Chapple, A., Chew-Graham, C., Dixon, C., Gask, L. et al. (2004). Framing the doctor-patient relationship in chronic illness: A comparative study of general practitioners' accounts. Sociology of Health & Illness, 26 (2). 135 - 158.
20. Medawar, C. (1992). Power and dependence. London: Social Audit.
21. Moncrieff, J. and Crawford, M.J. (2001). British psychiatry in the 20th century: Observations from a psychiatric journal. Social Science & Medicine, 53 (3). 349 - 356.
22. Moncrieff, J., Hopker, S. and Thomas, P. (2005). Psychiatry and the pharmaceutical industry. Psychiatric Bulletin, 29, 84 - 85.
23. North, D., Davis, P. and Power, A. (1995). Patient responses to benzodiazepine medication: A typology of adaptive repertoires developed by long-term users. Sociology of Health & Illness, 17 (5). 632 - 650.
24. Olson, M. and Pincus, H. (1994). Use of benzodiazepines in the community. Archives of Internal Medicine, 154 (11). 1235 - 1240.
25. Parr, J.M., Kavanagh, D.J., Young, R.M. and McCafferty, K. (2006). Views of general practitioners and benzodiazepine users on benzodiazepines: A qualitative analysis. Social Science & Medicine, 62 (5). 1237 - 1244.
26. Rogers, A. and Pilgrim D. (2001). Mental health policy in Britain. Basingstoke: Palgrave.
27. Stevenson, F.A., Britten, N., Barry, C.A., Bardley, C.P. and Barber, N. (2002). Perceptions of legitimacy: The infl uence on medicine taking and prescribing. Health: 6 (1). 85 - 104.
28. Stimson, G. and Webb, B. (1975). Going to see the doctor: The consultation process in general practice. London: Routledge & Kegan Paul.
29. Swartz, M.S., Swanson, J., Hiday, V.A., Borum, R., Wagner, R. and Burns, B.J. (1998). Taking the wrong drugs: The role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Social Psychiatry and Psychiatric Epidemiology, 33 (Supp. 1). S75 - S80.
30. Turner, B.S. (1991). Recent developments in the theory of the body. In M. Featherstone, M. Hepworth and B.S. Turner (Eds.), The body: Social processes and cultural theory, pp. 1 - 35. London: Sage.
31. Tyrer, P. (1987). Benefits and risks of benzodiazepines. Proceedings of the Royal Society of Medicines, 114, 7 - 11.
32. Tyrer, P., Harrison-Read, P. and van Horn, E. (1997). Drug treatment in psychiatry. London: Butterworth Heineman.